Genetic & Molecular Testing
Labs performing DNA, RNA, and genomic diagnostic tests.
Market snapshot
These figures describe Laboratory & Diagnostic Services (4.9.5), the segment that Genetic & Molecular Testing sits within. They are not figures for Genetic & Molecular Testing on its own.
- Market size
- ~$76B
- Growth
- ~10.1%CAGR (2017–22, nominal)
- Companies
- ~4,829 firms
75.3% of firms have fewer than 20 employees: 3,638 micro-businesses, below most mandates.
- 20–99
- 63453%
- 100–499
- 30926%
- 500+
- 24821%
~4,800 medical-lab and blood/organ-bank firms; the ~10%/yr growth and ~$76B are inflated by the 2022 COVID-testing surge and will normalize lower. It is a scaling, consolidating services layer (Labcorp and Quest at the top) with a long fragmented tail of specialty and reference labs: a deep strategic-buyer pool.
NAICS 621511, 621991. U.S. Census Bureau, 2022 Statistics of U.S. Businesses; U.S. Census Bureau, 2022 Economic Census.
Business model & economics
Revenue model
Per-test reimbursement across clinical and specialty testing
Key economics
- Revenue per firm
- $15,732,062
- Revenue per employee
- $224,750
- Employees per firm
- 67.5
- Recurring revenue
- Moderate–High
- EBITDA margin
- 15–25%
- Capex intensity
- High
recurring testing volume
Characteristics
- Balanced cost base: payroll is 29% of revenue, leaving room to scale margin without cutting staff
- Deep strategic-buyer pool: 248 firms exceed 500 employees, so a scaled asset has trade buyers
- Reference-lab market consolidated around Labcorp and Quest.
- COVID-testing surge inflated 2020–22, then normalized.
- Molecular and genetic testing the durable growth driver.
NAICS 621511, 621991. U.S. Census Bureau, 2022 Statistics of U.S. Businesses; U.S. Census Bureau, 2022 Economic Census.
M&A deal context
Who’s acquiring
- Reference-lab majors
- Genomic & specialty-testing acquirers
- PE-backed lab consolidators
What’s driving deals
- Acquisition of hospital outreach and specialty labs.
- Molecular and precision-diagnostics growth.
- Consolidation around scaled reference labs.
Find Genetic & Molecular Testing acquisition targets
Search Acquisera’s index for companies classified under Genetic & Molecular Testing (4.9.5.3) and build a targeted deal pipeline.
Search companies